ATC
DGX icon

Adirondack Trust Company’s Quest Diagnostics DGX Stock Holding History

Adirondack Trust Company’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.39K Hold
16
– – ﹤0.01% 509
2026
Q1 		$3.13K Hold
16
– – ﹤0.01% 486
2025
Q4 		$2.78K Hold
16
– – ﹤0.01% 491
2025
Q3 		$3.05K Hold
16
– – ﹤0.01% 468
2025
Q2 		$2.87K Hold
16
– – ﹤0.01% 436
2025
Q1 		$2.71K Hold
16
– – ﹤0.01% 438
2024
Q4 		$2.41K Hold
16
– – ﹤0.01% 448
2024
Q3 		$2.48K Hold
16
– – ﹤0.01% 451
2024
Q2 		$2.19K Hold
16
– – ﹤0.01% 458
2024
Q1 		$2.13K Buy
+16
New +$2.08K ﹤0.01% 467
2021
Q4 		– Sell
-50
Closed -$7K – 430
2021
Q3 		$7K Buy
+50
New +$7.32K ﹤0.01% 329
2019
Q4 		– Sell
-27
Closed -$3K – 349
2019
Q3 		$3K Hold
27
– – ﹤0.01% 316
2019
Q2 		$3K Hold
27
– – ﹤0.01% 326
2019
Q1 		$3K Hold
27
– – ﹤0.01% 317
2018
Q4 		$2K Buy
+27
New +$2.53K ﹤0.01% 331

Other funds holding DGX

EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
AIM
Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
JWM
JGP Wealth Management Bend, Oregon $1.11B AUM 35.22% 1-Year Est. Return
P
Paradiem Covington, Louisiana $464M AUM 45.56% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GIA
GHP Investment Advisors Denver, Colorado $2.72B AUM 27.58% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Adirondack Trust Company's DGX Position: Q2 2026 in Review

Adirondack Trust Company held its Quest Diagnostics (DGX) position steady in Q2 2026 at 16 shares worth $3.39K. The position accounts for ﹤0.01% of the portfolio, ranked #509.

Adirondack Trust Company first reported a position in DGX in Q4 2018 and has held it in 15 quarters since. The position peaked at $7K in Q3 2021. 159 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Adirondack Trust Company held 16 shares of Quest Diagnostics worth $3.39K as of Q2 2026.
  • Adirondack Trust Company left its Quest Diagnostics share count unchanged in Q2 2026.
  • Quest Diagnostics made up ﹤0.01% of Adirondack Trust Company's portfolio in Q2 2026, its #509 holding.
  • Adirondack Trust Company first reported a position in Quest Diagnostics in Q4 2018 and has held it in 15 quarters since.
  • Adirondack Trust Company's Quest Diagnostics position peaked at $7K in Q3 2021.
  • 159 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Adirondack Trust Company's 13F filing for Q2 2026, filed 16 Jul 2026.